1. Home
  2. CTXR vs FOXX Comparison

CTXR vs FOXX Comparison

Compare CTXR & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • FOXX
  • Stock Information
  • Founded
  • CTXR 2007
  • FOXX 2017
  • Country
  • CTXR United States
  • FOXX United States
  • Employees
  • CTXR N/A
  • FOXX N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • FOXX
  • Sector
  • CTXR Health Care
  • FOXX
  • Exchange
  • CTXR Nasdaq
  • FOXX Nasdaq
  • Market Cap
  • CTXR 19.8M
  • FOXX 16.9M
  • IPO Year
  • CTXR N/A
  • FOXX N/A
  • Fundamental
  • Price
  • CTXR $1.49
  • FOXX $4.39
  • Analyst Decision
  • CTXR Buy
  • FOXX
  • Analyst Count
  • CTXR 2
  • FOXX 0
  • Target Price
  • CTXR $6.00
  • FOXX N/A
  • AVG Volume (30 Days)
  • CTXR 570.6K
  • FOXX 2.7M
  • Earning Date
  • CTXR 12-26-2025
  • FOXX 11-18-2025
  • Dividend Yield
  • CTXR N/A
  • FOXX N/A
  • EPS Growth
  • CTXR N/A
  • FOXX N/A
  • EPS
  • CTXR N/A
  • FOXX N/A
  • Revenue
  • CTXR N/A
  • FOXX $63,030,415.00
  • Revenue This Year
  • CTXR N/A
  • FOXX N/A
  • Revenue Next Year
  • CTXR $731.60
  • FOXX N/A
  • P/E Ratio
  • CTXR N/A
  • FOXX N/A
  • Revenue Growth
  • CTXR N/A
  • FOXX 139.29
  • 52 Week Low
  • CTXR $0.65
  • FOXX $1.71
  • 52 Week High
  • CTXR $5.95
  • FOXX $11.00
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 59.09
  • FOXX 58.87
  • Support Level
  • CTXR $0.97
  • FOXX $1.71
  • Resistance Level
  • CTXR $1.18
  • FOXX $6.90
  • Average True Range (ATR)
  • CTXR 0.12
  • FOXX 0.90
  • MACD
  • CTXR 0.03
  • FOXX 0.26
  • Stochastic Oscillator
  • CTXR 84.72
  • FOXX 53.18

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About FOXX Foxx Development Holdings Inc. Common Stock

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.

Share on Social Networks: